0455.HK - Tianda Pharmaceuticals Limited

HKSE - HKSE Delayed Price. Currency in HKD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2019
3/31/2018
3/31/2017
3/31/2016
Total Revenue
523,333
527,003
361,555
195,539
192,785
Cost of Revenue
109,514
102,923
91,195
75,524
82,056
Gross Profit
413,819
424,080
270,360
120,015
110,729
Operating Expenses
Research Development
-
6,916
3,139
3,025
1,213
Selling General and Administrative
398,444
407,931
252,247
99,536
101,189
Total Operating Expenses
401,956
411,440
253,582
100,649
101,462
Operating Income or Loss
11,863
12,639
16,778
19,366
9,267
Interest Expense
-
-
-
-
0
Total Other Income/Expenses Net
-
-
-
-
-
Income Before Tax
22,819
26,167
29,942
32,750
18,425
Income Tax Expense
9,279
10,184
7,780
7,997
5,058
Income from Continuing Operations
13,540
15,983
22,162
24,753
13,367
Net Income
2,761
2,657
10,008
12,442
6,569
Net Income available to common shareholders
2,761
2,657
10,008
12,442
6,569
Reported EPS
Basic
-
0.00
0.00
0.01
0.00
Diluted
-
0.00
0.00
0.01
0.00
Weighted average shares outstanding
Basic
-
2,150,192
2,150,620
2,150,636
2,050,232
Diluted
-
2,150,192
2,150,620
2,150,636
2,050,232
EBITDA
-
28,806
42,563
40,757
39,514